News Headlines Article

FDA program targets misleading ads
Modern Healthcare

The Food and Drug Administration’s Center for Drug Evaluation and Research has launched an outreach effort that seeks healthcare providers’ help in identifying misleading prescription-drug advertising and marketing practices. The effort, tagged the Bad Ad Program, is aimed at helping FDA officials identify misleading promotional activities targeted at providers, as well as consumer ads that downplay drug risks and effectiveness, according to a news release.